Radian (RDN) Q2 2026 Earnings Call Transcript

Radian Group reported Q2 2026 total revenue of $575M (+93% YoY) and adjusted diluted net operating EPS of $1.14 (vs. $1.11 in Q2 2025), with book value per share rising 8.5% to $36.0. Mortgage insurance delivered record $284B of primary insurance in force (+3% YoY) and a 35.8% mortgage combined ratio, while the Specialty segment’s combined ratio was 97.7% (93% for 1H, with a ~$30M Middle East-related reserve impact). Management raised 2026 dividend expectations to at least $650M (from $600M) and guided Specialty earned premiums to +20% in 2H 2026, despite softer specialty rates.

Analysis

The market’s first-order read is likely “beat plus buybacks,” but the cleaner mechanism is capital compounding: the mortgage arm is still funding upstream cash while the specialty build is starting to add earnings power. That combination can justify a rerating if investors stop valuing RDN like a stuck-runoff MI name and start treating it as a two-engine insurer with more flexible capital allocation than peers. The best relative winners are shareholders, not competitors: higher upstream cash and continued repurchases should mechanically lift per-share value even if consolidated growth slows.

The risk is that specialty underwriting is entering the wrong part of the cycle just as the mix shifts away from the historically more predictable MI book. Softening rates in property/reinsurance usually show up with a lag of 1-3 quarters via lower new business economics and weaker renewal pricing, so the next few prints matter more than the current one. If the specialty combined ratio stays in the mid/high 90s ex one-offs, the market will likely cap the multiple despite the buyback story.

Contrarian take: consensus may be over-penalizing the Middle East reserve and underestimating the structural value of the mortgage cash engine. The bigger miss is probably not the reserve itself, but whether the market believes management can keep specialty growth selective without sacrificing margin. If that discipline holds, RDN can still work as a cash-return story over 6-12 months; if not, the stock becomes a capital-return shell with lower-growth specialty attached.

Key Decisions for Investors

• Long RDN common for 1-3 months: buy on any post-earnings consolidation rather than strength-chasing; upside comes from buyback acceleration and higher expected upstream dividends, with a plausible 10-15% rerating if specialty margins stabilize.
• Pair trade: long RDN / short MTG over 3-6 months if you want MI cash flow plus special-situation capital return; thesis is RDN’s incremental repurchases and specialty optionality vs. MTG’s more plain-vanilla MI exposure.
• Set a risk alert on RDN specialty combined ratio >95% ex Middle East reserves in the next 1-2 quarters; that would argue the soft-market pressure is reaching earnings faster than management expects and would likely cap the multiple.
• If buying the common, use a stop/review level on a sharp drop in mortgage persistency or NIW momentum over the next 2 quarters; lower rates that trigger refi attrition would undercut the cash engine supporting buybacks.
• Watch for a post-divestiture capital deployment update around the 2027 maturity/refi: if debt is refinanced cleanly and buybacks stay near the upper end of guidance, the stock can re-rate further over 6-18 months.